NASD · Healthcare · Drug Manufacturers - Specialty & Generic · China
China SXT Pharmaceuticals Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the China SXT Pharmaceuticals Inc stock.
No reliable verdict: intrinsic value $42.94 per share, market price $3.25 (as of 2026-10-30).
Its current assets minus all its liabilities would put the shares at $42.94: 13 times the price of $3.25. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
All 84 Drug Manufacturers - Specialty & Generic stocks
We do not publish a verdict on SXTC. Its current assets minus all its liabilities would put the shares at $42.94: 13 times the price of $3.25. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
We do not publish one (as of the 2026-10-30 close). Its current assets minus all its liabilities would put the shares at $42.94: 13 times the price of $3.25. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.